Prostate Cancer

Prostate Cancer is the most common cancer for men in the UK. 1 in 8 men will be diagnosed with it in their lifetime. Below is a collection of reports on some of TUF's groundbreaking research in this vital area.


The Urology Foundation has a variety of funds for urologists.  The reports below were funded under one of the following programmes:

Research Scholarship - RS

Smaller Research Projects Fund - SRPF

Fulbright Scholarship - FS

Other - OTHER (See report for further details of funding)

The development and implementation of an individualised prognostic modelling tool for nonmetastatic prostate cancer: PREDICT Prostate

Read about 2017 TUF Medal Winner David Thurtle's development of this important tool for prostate cancer patients.

Read more

[OTHER] Investigating interactions between vacuolar ATPase proton pumps and androgen receptor signalling in prostate cancer

Simon Crabb's project had this hypothesis: "V-ATPases would activate and drive activity of the androgen receptor in prostate cancer".

Read more

Estrogen receptor beta is an important modulator of prostate carcinogenesis

Adam Nelson's project looked at the role of estrogen in prostate cancer development

Read more

Biomarkers in Prostate Cancer

Sheng-Fei Oon used TUF funding to help research new and more accurate ways of testing for prostate cancer - with promising early results.

Read more

Events for professionals